Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...

—Researchers recently examined how different iron chelation medications—deferoxamine, deferiprone, and deferasirox—impacted iron stores and long-term health in patients with transfusion-dependent ...

CHELATION THERAPY HAS been around for decades as a treatment for toxic metal poisoning. But, there have also been claims that the therapy could help several other conditions. Experts aren't so sure.

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced updated data from patients with beta-thalassemia who require regular blood transfusions treated with betibeglogene ...

β-Thalassemia is a genetic disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin, leading to ineffective erythropoiesis and severe anemia. Patients with ...

Transfusion-dependent β-thalassemia (TDT) patients in France face significant health care demands and clinical challenges, with frequent complications and high mortality rates. Patients with TDT ...

Myelodysplastic syndromes (MDS) often require frequent blood transfusions for anemia, which can lead to iron overload. Over time, extra iron can damage organs throughout the body. Underlying MDS ...

MORE than 9,000 persons are being treated for thalassaemia in public hospitals, with each patient chalking up treatment costs ...